Os resultados tão esperados do ensaio clínico, randomizado, c placebo do #Remdesevir no @NEJM: 1. Diminuiu tempo de recuperação em 27% 2. Reduziu óbitos em 30% 3. Efeitos adversos < em tratados vs. placebo Seguro e comprovadamente eficaz contra #COVID-
RT @roby_bhatt: My take on the long-awaited remdesivir trial (ACTT-1) - because Twitter needs more takes: - primary outcome convincingly re…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Remdesivir for the Treatment of #COVIDー19 — Preliminary report concludes Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection. https://t.co/LcGsE3g0aW
Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/fre0uczMh4
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM. Acorta los días de recuperación de 15 a 11 y baja el score de enfermedad en forma no significativa, igual la pregunta sigue, Sirve??? Fallecen un poco menos el grupo q recibe Remdesivir
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
RT @DrJulioSandoval: Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM Buenas noticias! https://t.co/Cr4rh1cUNu
My take on the long-awaited remdesivir trial (ACTT-1) - because Twitter needs more takes: - primary outcome convincingly reached: 4d faster recovery - shortening illness is NOT a trivial outcome in a disease that's overwhelmed multiple health systems http
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @drmiguelmarcos: Resultados del Remdesivir en el @NEJM No es ninguna maravilla y desde luego no hemos encontrado la "bala mágica", per…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
So now the LARGE Multinational Registry Analysis for HCQ is done. And the REMDESIVIR as well. HCQ DOESNT work at all, it is now proven the president is dumb for taking it. REMDESIVIR only can be effective if taken super early.
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @jeremyfaust: The ACTT-1 Remdesivir trial is finally published! The one Fauci spoke of a few weeks back. Some patients indeed recovere…
RT @jsenior64: Ensayo ACTT remdesivir vs placebo. Una mirada al diseño, conducción y resultados deja sabor agridulce. Aspectos interesantes…
RT @AndyBiotech: #COVID19 Biggest new info in #Remdesivir NIAID full data was no benefit in patients on mechanical ventilation or ECMO. Th…
RT @carvicab: La ciencia se toma su tiempo #Remdesivir
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @hswapnil: Ladies and gentlemen It’s finally here https://t.co/HUMWff7wVw Not quite a miracle - but a first step? https://t.co/QzdVQ…
RT @ArvinderSoin: Early Results from a big Remdesivir study! (https://t.co/dyFohy4dqt) Good News: Safe & Effective for quicker recovery fr…
RT @DrJulioSandoval: Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM Buenas noticias! https://t.co/Cr4rh1cUNu
'Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 11 days, as compared with 15 days; rate ratio for recovery, 1.32; 95% confidence interval [CI], 1.12 to 1.55; P<0.001; 1059 patients' https://
RT @ArvinderSoin: Early Results from a big Remdesivir study! (https://t.co/dyFohy4dqt) Good News: Safe & Effective for quicker recovery fr…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
A ver que dice, esperanzador? No lo creo https://t.co/ZQyHKciWsL
RT @DocDrMulasli: Remdesivir isimli ilacın işe yaramadığı ile ilgili bir çalışma yapılmıştı Çinliler tarafından... Başka bir grubun yaptığ…
Remdesivir was superior to placebo in shortening the time to recovery in adults 図で民族差が多少あるかなってのと、重症では回復がプラセボのがやや良いのが気になります。でも14日以内の致死率は、全群で差が顕著に付いてなさそうですが、投薬群が悪いことはなさそうな?
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @ernestocardio: Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/JP1RaCI4Bf @drjarayg @jstragazue @menc…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @ernestocardio: Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/JP1RaCI4Bf @drjarayg @jstragazue @menc…
RT @srrezaie: IMPORTANT --> RCT of Remdesivir vs Placebo in >1000pts Median Recovery Time: Remdesivir -> 11d Placebo -> 15d https://t.co/…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @HelenChuMD: An incredibly challenging study to do during a pandemic - the consenting alone required creating a massive flow chart. Late…
RT @DrSamuelBrown: Finally some actual data on remdesivir: https://t.co/Z6TMct1rbM
RT @zchagla: The infamous NIAID study published by Fauci. Seen here: https://t.co/njlGckc4AP Big takeaways 1) Congratulations on organizi…
Remdesivir informe preliminar para el tratamiento Covid-19 https://t.co/E1mBKeECF2
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @Luis_Corral_Gud: Era cuestión de tiempo que llegasen ensayos clínicos de calidad. Hoy, por fin, NEJM nos deleita con uno sobre Remdesiv…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @DrEricDing: New: the NIH led Remdesivir trial with 1000 patients finally published. 11 days on R vs 15 days placebo: 32% faster rate of…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @TayeBalcha: A Randomised Clinical Trial showed that a 10-day course of IV remdesivir was superior to placebo in shortening the time to…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…
RT @hswapnil: Ladies and gentlemen It’s finally here https://t.co/HUMWff7wVw Not quite a miracle - but a first step? https://t.co/QzdVQ…
RT @drmiguelmarcos: Resultados del Remdesivir en el @NEJM No es ninguna maravilla y desde luego no hemos encontrado la "bala mágica", per…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @TayeBalcha: A Randomised Clinical Trial showed that a 10-day course of IV remdesivir was superior to placebo in shortening the time to…
Remdesivir acorta días de internamiento, pero no mejora la mortalidad https://t.co/THtN0aDMXH
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @ernestocardio: Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/JP1RaCI4Bf @drjarayg @jstragazue @menc…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @Shora: Ya han salido los resultados preliminares del gran ensayo clínico sobre remdesivir (del que se había hablado tanto sin que los r…
RT @banavarrete: El estudio de Remdesivir acaba de salir publicado en @NEJM. Intento leerlo y después doy mis comentarios. A primera vista:…
NEJMよりcover-19に対するRCTの報告。 効果はありそうですね。 https://t.co/OGYYGvrDdt
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
La ciencia se toma su tiempo #Remdesivir
RT @AlistairHaimes: https://t.co/jt5Vn8hy9r More details of the now famous study released yesterday. 80% reduction in mortality for those…
Good news
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @jeremyfaust: The ACTT-1 Remdesivir trial is finally published! The one Fauci spoke of a few weeks back. Some patients indeed recovere…
RT @vishalgulati_: Randomised, placebo controlled study of Remdesivir for the Treatment of Covid-19 Bottom line: Better to have it than n…
RT @hswapnil: Ladies and gentlemen It’s finally here https://t.co/HUMWff7wVw Not quite a miracle - but a first step? https://t.co/QzdVQ…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @Shora: Ya han salido los resultados preliminares del gran ensayo clínico sobre remdesivir (del que se había hablado tanto sin que los r…
RT @Shora: Ya han salido los resultados preliminares del gran ensayo clínico sobre remdesivir (del que se había hablado tanto sin que los r…
RT @virolvlog: نتائج التجربة السريرية التي انتظرناها نشرت اليوم في NEJM. كما علمنا مسبقاً من البيان الصحفي، تفوق Remdesivir على الدواء الوه…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
لا تتوقع علاج دوائي ناجع الامل كما هي الحال مع الفيروسات في التطعيم.
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @findingpneumo: Great to see the actual clinical data - better response in milder disease may be due to greater impact when viral loads…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @AndyBiotech: #COVID19 Biggest new info in #Remdesivir NIAID full data was no benefit in patients on mechanical ventilation or ECMO. Th…
RT @gorka_orive: Ensayo clínico randomizado y controlado con placebo de Remdesivir en 1063 pacientes hospitalizados con #COVID19: 1. Menor…
RT @PabloFuente: #COVID19 Informe preliminar sobre el Remdesivir. Parece tener algunos beneficios (mejor recuperacion, menos muertes), pero…
RT @KiraNewmanMDPhD: #Remdesivir for #COVID19 RCT is finally out @NEJM! -Shorter time to recovery (11 v. 15 days in placebo group) -Lower m…
RT @laoneill111: Remdesivir anti-viral published last night. Clear benefit to patients with less severe disease so a start. Treat early. ‘…